A School-Based Intervention Using Insulin Degludec to Reduce Pediatric Readmissions for Diabetic Ketoacidosis

Authors

Patrick Hanley, MD, Thomas Jefferson UniversityFollow

Document Type

Presentation

Publication Date

4-21-2021

Comments

Presentation: 38:13

Abstract

Diabetic ketoacidosis (DKA) is the leading cause of morbidity and mortality in children with diabetes. Children with diabetes are most often readmitted to the hospital with DKA due to missed daily basal insulin. This project describes a quality improvement project at Nemours Alfred I duPont Hospital for Children focused on reducing DKA readmissions. The project used a standardized approach for pediatric patients with established diabetes readmitted with DKA. The project utilized a school-based intervention in conjunction with changing to insulin degludec at school with a goal to reduce DKA readmissions by 25% by the end of the project.

Recommended Citation

Hanley, MD, Patrick, "A School-Based Intervention Using Insulin Degludec to Reduce Pediatric Readmissions for Diabetic Ketoacidosis" (2021). Master of Science in Healthcare Quality and Safety Capstone Presentations. Presentation 53.
https://jdc.jefferson.edu/ms_hqs/53

Language

English